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Abstract 
Background: Alarming rates of unhealthy alcohol, non-prescription drug, and tobacco use highlight the preventable 
health risks of substance abuse and the urgent need to activate clinicians to recognize and treat risky use. Screening, 
brief intervention, and referral to treatment (SBIRT) is an efficacious and effective processes to identify, reduce and 
prevent risky use of substances. This paper describes a study protocol testing implementation of a toolkit to enhance 
use of SBIRT in acute care settings to recognize and address patient risky alcohol, drug, and tobacco use.
Methods: This study uses a phased cluster randomized mixed method design to test nurse-led implementation of 
an SBIRT toolkit on one medical-surgical unit at 14 acute care hospitals (critical access, community and academic 
health centers). Medical surgical units will be randomly assigned to implement the SBIRT toolkit (engagement and 
communication, assessment, planning, training, and evaluation tools) or a wait-list usual care control group that 
begins implementation 6 months later. Primary endpoints are documentation of SBIRT delivery in randomly selected 
electronic medical records at baseline, 6 months and 12 months after group 1 implementation (61 records per unit 
per time period, N = 2562). Two surveys will be administered to unit nurses: smoking cessation activities will be 
assessed at baseline and SBIRT use will be assessed on randomly-selected days after implementation. In addition, site 
coordinators will complete a baseline capacity assessment, an implementation fidelity survey post-implementation, 
and a structured interview at the end of the study. Multilevel mixed-effects effects logistic and linear models will be 
used to analyze use of SBIRT and cost outcomes.
Discussion: This study will guide subsequent SBIRT implementation, dissemination, and spread across rural, commu-
nity and urban healthcare systems throughout the state and beyond. The long-term objective is to activate clinicians 
to recognize, intervene and refer people with risky substance use to improve health and decrease substance use 
disorders.
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Background
According to the World Health Organization, mental 
health and substance use disorders will surpass all physi-
cal diseases as a major cause of disability worldwide by 
2020 [1]. In the United States, the annual total estimated 
societal cost of substance use disorders is $510.8 billion 
[2]. The negative outcomes and costs associated with 
substance use are not exclusive to any specific substance. 
For example, alcohol use is linked to significant economic 
and health costs on a global scale [3]. It is often a con-
tributing factor in homicides, suicides, crimes (violent, 
including homicide, and non-violent), motor vehicle col-
lisions (non-fatal and fatal), and unintentional injuries to 
the drinker and others in his/her environment [4]. Heavy 
drinking can lead to a pattern of abuse and/or depend-
ence that is often associated with other harmful behav-
iors such as cigarette smoking, unsafe sex, and illicit drug 
use [5]. Even lower levels of drinking, while potentially 
asymptomatic, are associated with health risks [6].
In addition, despite a steady decline in smoking rates 
among the general population over the past several 
decades, tobacco use remains the primary known pre-
ventable cause of morbidity and mortality in the United 
States, resulting in an estimated 480,000 deaths annually 
from tobacco-attributable diseases [7]. Quitting smoking 
has a greater impact on cardiovascular risk than changes 
in blood pressure, weight, physical activity, or lipids 
[8]. Finally, and of particular relevance to the national 
public health and medical infrastructure in the United 
States, the rate of non-medical prescription pain reliever 
use reported in 2014 by US residents between the ages 
of 18–25 was 2.8% [9]. Further, between 2004 and 2009, 
emergency department visits increased 98.4% in the US 
related to  non-medical use of prescription drugs [10]. 
These data have meaningful implications for the US 
healthcare system. Over 36.5 million adults are admitted 
annually to acute care hospitals in the US [11]. In such 
settings, approximately one-third of adult patients screen 
positive for high-risk drinking or drug use [12].
One promising public health response to this problem 
is screening, brief intervention, and referral to treatment 
(SBIRT), which is a comprehensive, integrated approach 
to the delivery of early intervention and referral to treat-
ment services for persons at risk for or with substance 
use disorders and/or tobacco use and dependence [13]. 
Rather than a specific, individual service, SBIRT is a 
patient care framework based on identifying risk via 
validated screening tools, intervening on that risk in 
a manner that is clinically appropriate, and referring to 
specialty treatment when the risk cannot be managed 
on-site [14]. Data from a large cross-site evaluation from 
diverse healthcare sites (n = 754,525) indicate that most 
patients who screen positive are recommended for a brief 
intervention (BI 68.8%), followed by brief treatment (BT 
14.0%) and referral to specialty treatment (RT 17.2%) 
[15]. However, SBIRT screening in hospital settings tends 
to identify both a higher frequency of positive screens 
for alcohol and increased severity level of those screen-
ing scores, relative to outpatient primary care, indicating 
greater likelihood of patients needing referral [16, 17].
The evidence basis for SBIRT is complex and varies 
considerably by type of substance, activity, and severity 
of use. Brief interventions (BI) for unhealthy alcohol use 
(‘misuse’) are supported by a systematic reviews [18–20] 
as well as the largest SBIRT evaluation study to date [15]. 
Alcohol BIs have also demonstrated efficacy for under-
age drinkers in the ED [21]. However, alcohol BI does 
not appear to be efficacious for very heavy or depend-
ent users [22]. Further, a recent meta-analysis found no 
evidence that BI, naturally results in engagement with 
alcohol-related care [23], though other researchers have 
disputed this claim [24]. Few SBIRT studies focus spe-
cifically on outcomes from referral to treatment (RT) for 
alcohol [25], sometimes due to difficulty disentangling 
the type of service provided [26], though the cross-site 
evaluation from SAMHSA’s SBIRT initiative reported 
a moderate/large effect for RT [15]. Due to this deficit 
in the literature, one research team recently conducted 
a proof-of-concept study for their alcohol RT, yielding 
promising results for patient engagement with treatment 
post-SBIRT [27].
SBIRT for tobacco use provides a variety of intervention 
types ranging from minimal interventions (brochures) to 
BIs, nicotine replacement therapy (e.g., nicotine patches), 
and quit line referral. Evidence for these components has 
generally supported moderate effects on tobacco absti-
nence, especially for BI or BI with nicotine replacement 
[7, 28–33]. Some of the research indicates that even min-
imal tobacco-centric interaction (less than a BI) may have 
an effect on abstinence [29]. The specific effects of any 
given component or mixture of components continue to 
be under investigation, such as in a recent (2018) 16-arm 
factorial study protocol of tobacco SBIRT focusing on BI, 
nicotine replacement, quit line referral, and smoke-free 
text messaging [34].
However, extant evidence supporting SBIRT for other 
substances is less well established. Some studies and 
reviews support SBIRT for other substances [14, 35–39]. 
However, other recent studies found no evidence of effi-
cacy for BI for other substances [40–43], no evidence that 
BI for other substances reduces negative consequences 
of drug use [44], and no evidence that BI [43, 45] or RT 
[42] for other substances increases receipt of treatment. 
A recent meta-analysis on this subject concluded that the 
current evidence basis is generally insufficient to make 
a determination [46]. However, DiClemente’s review of 
Page 3 of 10Newhouse et al. Addict Sci Clin Pract           (2018) 13:28 
reviews did find support of motivational interviewing 
(MI) for marijuana, while retaining the perspective of 
insufficient evidence for other substances (e.g., metham-
phetamine and opiates) [18]. A recent, innovative modi-
fication of SBIRT, called STIRT (screening, treatment 
initiation, and referral to treatment), included revised 
protocols and medication-assisted treatment for opioid 
dependent patients. In a randomized trial, the authors 
reported increased engagement in opioid treatment and 
abstinence at 30 days compared to traditional SBIRT and 
control groups [47].
The SBIRT process is a complex clinical process 
encompassing multiple components and activities, each 
of which are often not documented thoroughly, resulting 
in a body of literature that can be difficult to interpret. 
O’Donnell and colleagues identified a variety of papers 
pointing to a ‘lack of training or suitable intervention 
materials’ as one of several implementation-level barriers 
to SBIRT [48]. Findings in the SBIRT literature are also 
mixed, and differentials in implementation strategies may 
also account for some of the variance in SBIRT trial out-
comes [18, 46]. One clear conclusion that can be drawn is 
that there is a need for randomized trials that thoroughly 
describe and test specific implementation methods. As 
a result, this proposed study will examine the impact 
SBIRT implementation on processes of care across rural, 
community and urban acute-care hospitals
In particular, this project challenges and seeks to shift 
current clinical practice paradigms within hospitals by 
examining the process outcomes associated with a stand-
ardized SBIRT process and workforce training toolkit for 
hospital nurses. Recent research has supported SBIRT 
training for nurses both as part of academic curricula [49, 
50] and as part of quality improvement [51]. The extant 
patient flow within the hospital system selected for this 
trial has been responsive to the 2006 Institute of Medi-
cine recommendation to coordinate mental health and 
substance use services with general health care [52]. But 
even though hospitalized patients are asked about their 
substance use on admission, validated screening tools are 
rarely used, brief interventions are often not conducted, 
and referrals for treatment are not completed. A hospi-
tal admission offers an opportunity for nurses to iden-
tify and intervene with patients who are currently using 
substances at a time when they are already seeking pro-
fessional care. The health system is therefore ideal for a 
cluster randomized mixed method approach testing the 
effectiveness of a toolkit on implementation of SBIRT.
Our prospective study is innovative and promising on 
multiple levels. It is likely that results will provide infor-
mation that will support the standardization of both the 
SBIRT processes and mechanisms of workforce train-
ing to address a significant behavioral health problem 
(substance use) that can be deployed across the health 
system. This includes both the consistency of inpatient 
hospital screening and brief intervention and advancing 
community partnerships for referral to treatment and 
assessing long-term outcomes. As observed in prior lit-
erature, many complexities in interpreting current SBIRT 
literature result from non-standardized implementation 
and effectiveness efforts. Therefore, studying implemen-
tation is a crucial aspect of the protocol. This approach: 
(1) utilizes a conceptual framework that maximizes 
facility engagement in the adoption and implementa-
tion of SBIRT; (2) creates buy-in from key stakeholders 
through the use of a train-the-trainer approach; (3) gen-
erates outcome data to facilitate future innovations in 
practice; (4) produces a SBIRT toolkit with procedures, 
tools, instruments, implementation guide, and resources 
to disseminate and sustain SBIRT use; (5) employs an 
interprofessional team of researchers, educators, and cli-
nicians; and (6) facilitates the adoption of SBIRT across 
the health system.
Our proposed study partners with a large health sys-
tem in Indiana and aligns with the State of Indiana Sub-
stance Abuse Prevention and Mental Health Promotion 
Strategic Plan (2012–2017) [53] by implementing SBIRT 
to improve the identification of people with at risk drug, 
alcohol or tobacco use, brief interventions and referral 
to treatment (when indicated). The short-term goal is to 
inform SBIRT implementation methods for use across 
rural, community and urban settings. The long-term goal 
is to develop an SBIRT toolkit with procedures, tools, 
instruments, implementation guide, and resources to 
disseminate and sustain SBIRT use to improve access to 
quality care and outcomes for people that use tobacco, 
non-prescription drugs, and/or drink an unhealthy 
amount of alcohol.
The purpose of this study is to examine SBIRT imple-
mentation methods across rural, community and urban 
acute hospital settings. The first aim is to test if imple-
mentation of SBIRT improves care delivery and referral 
of hospital inpatients currently using tobacco, alcohol or 
non-prescription drugs. The second aim is to evaluate 
the cost of SBIRT implementation and delivery for the 
healthcare system.
In US acute care settings, an estimated 1.8 million 
annual inpatient stays are primarily due to a behavioral 
health or substance use disorder [54], despite concerted 
national efforts to reduce the prevalence and incidence 
of these risky behaviors. There remains an urgent need to 
advance behavioral health care practices using sophisti-
cated and deliberative approaches to implementation. As 
this section has demonstrated, the phased cluster rand-
omized approach of SBIRT described here is the next 
step to advance knowledge about how best to implement 
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SBIRT and if implementation improves use of the SBIRT 
process moving forward.
Methods
Conceptual framework
The Model for Considering the Determinants of Diffu-
sion, Dissemination and Implementation of Innovations 
in Health Services Delivery and Organization guides 
this study [55]. This model frames what is known about 
the adoption of innovations within organizations and 
guides successful implementation of innovations. The 
foundation for the conceptual model is based on a nar-
rative synthesis of theory and research that guides effec-
tive implementation of innovations in organizations. No 
one intervention is always effective, and interventions are 
likely to be more effective if based on assessment of bar-
riers, use multiple strategies, and are system focused [55].
Antecedents are attributes of the hospital, such as 
structural aspects and leadership support that foster 
incorporation of new evidence, making the organiza-
tion receptive to change. Readiness is the organization’s 
receptiveness to change, including support and advo-
cacy for the change and dedicated time and resources. 
Antecedents and readiness are determined through an 
organizational assessment. Adoption and/or assimila-
tion represent the process of incorporation of new evi-
dence into practice. This study includes SBIRT training 
and nurse SBIRT knowledge (test) and competency (skill 
validation). Implementation is the actual use of the new 
evidence. In this study, implementation includes the use 
of SBIRT (survey randomly selected days) and smoking 
cessation counseling (Smoking Cessation Counseling 
Scale). Consequences are the result or outcome of adop-
tion of new evidence. In this study, the consequences are 
SBIRT documentation included in the Electronic Medical 
Record (EMR) and patient follow-up if they are referred 
for treatment [55].
Description of intervention
This study protocol will incorporate standardized edu-
cation on SBIRT through a train-the-trainer approach. 
Registered Nurse site coordinators from each hospital 
will receive 8  h of training on the SBIRT process, sys-
tem strategies to facilitate organizational uptake, and 
how to teach SBIRT to others. Study investigators will 
develop this training. The training will be informed 
by information from the Substance Abuse and Mental 
Health Services Administration’s public health model 
of universal screening, early intervention, and treat-
ment for people who have problematic or hazardous 
alcohol, drug, or tobacco use and dependence, as well as 
content from the Indiana Prevention Resource Center 
and Institute for Research on Addictive Behavior. After 
the site coordinator training is complete, site coordina-
tors at each facility will train additional clinical nurses 
in SBIRT and develop a referral process specific to their 
organization’s needs and resources. The site coordina-
tors may also partner with additional staff within their 
hospital, including social workers and respiratory thera-
pists, to encourage widespread adoption. The site coor-
dinators will partner with unit leaders at each facility to 
decide how many additional clinical nurses will receive 
SBIRT training and which employees will receive train-
ing. These training interventions are reproducible, publi-
cally available, and do not require direct control from the 
research team. During training, the site coordinators will 
receive a toolkit that includes the standardized educa-
tion, engagement and communication tools, assessment 
tools, planning tools, and evaluation tools to assist with 
implementation at their facility.
In addition to the toolkit and preparation of site coor-
dinators, the investigators will use several strategies to 
facilitate implementation. Investigators will provide 
ongoing consultation to the site coordinators about 
SBIRT and implementation. Each month, the investi-
gators and site coordinators will participate in a team 
meeting to discuss implementation barriers and facili-
tators. Site coordinators will be able to share tools they 
have developed and strategies they have used to promote 
implementation. Investigators will encourage adaptabil-
ity of the intervention to the organizational context while 
preserving fidelity. The investigators may also make site 
visits to support implementation of SBIRT and SBIRT 
education. At the completion of the study, the site coor-
dinators and investigators will work together to enhance 
the toolkit that was provided during training.
Study subjects
This study will be conducted at a large healthcare sys-
tem in the Midwest. Table  1 includes a description of 
the hospital sites, type and bed size. The hospital sample 
includes four community hospitals, four academic health 
centers, and six critical access hospitals with bed size 
ranges from 15 to 858 beds.
Study design and sample
A phased cluster randomized mixed methods design will 
be used for this study. Each hospital within the healthcare 
Table 1 Hospital characteristics by type (N = 14)
N Bed range Mean beds
Academic Health Centers 4 38–858 413
Community Hospitals 4 127–375 214
Critical Access Hospitals 6 15–25 23
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system is eligible to participate, and the chief nursing 
officer of each hospital (N = 14) submitted a letter of sup-
port for the study. One medical surgical unit within each 
hospital will be selected by the nurse executive to partici-
pate. This selection will be based on the nurse executive’s 
assessment of the nursing unit capacity to participate in 
the study and implement a change in practice.
A computer-generated allocation based on a stratified 
random sampling approach using STATA will be used 
to randomize hospitals into an intervention or wait-list 
usual care control group. Prior to randomization, hos-
pitals will be stratified by type (academic health center, 
community hospital, or critical access hospital). Alloca-
tion to the intervention or wait-list usual care control 
groups will be based on cluster, and participants will be 
notified of their cluster allocation. Participants in the 
control group will provide the usual care that is standard 
for that facility, and then the site coordinators will receive 
the intervention 6 months after participants in the inter-
vention group (Table 2).
All hospitals will receive the intervention. Group 1 
(n = 7) hospitals will participate in the implementa-
tion intervention first, with Group 2 (n = 7) following 
6 months later. Using this phased approach allows for 
comparisons between a control and intervention group, 
as well as within hospital changes longitudinally, and 
ensures there are no ethical concerns related to withhold-
ing the SBIRT implementation.
Data sources
To evaluate SBIRT implementation, several data sources 
will be used as summarized in Table  3. To assess ante-
cedents to change and readiness for change, the site 
coordinators will complete a baseline assessment of their 
hospital for structural capacity (e.g., buy in of stakehold-
ers), staff capacity (e.g., staff competencies), organi-
zational support (e.g., leadership support), technical 
capabilities (e.g., access to technology), and fiscal capac-
ity (e.g., nurse staffing resources). The qualitative and 
quantitative baseline assessment was developed by the 
investigators and will be used to identify areas that need 
to be addressed before implementation of the study. The 
site coordinators and investigators will use this data to 
develop a facility-specific plan to address gaps prior to 
implementation.
To assess adoption and assimilation at the comple-
tion of SBIRT training, site coordinators and direct care 
nurses will complete a 10-item test constructed for this 
Table 2 Study design
Collect pre-data Intervention Collect 6-month 
data
Collect 
12-month 
data
Group 1 (Intervention Group) 01 × 02 03
Group 2 (Wait-List Usual Care Control 
Group)
01 ×
(6 months after Group 1)
02 03
Table 3 Conceptual framework concepts and operationalization
SC site coordinator, RN All direct care nurses on study unit, SN all trained nurses
Concepts Operationalized Timing
Antecedents Organizational attributes (SC) Program development
Readiness Attributes of nurses (RN) Before implementation
Adoption SBIRT Knowledge (SN) Post training
Brief Intervention Adherence and Competency Scale (observation of SN by SC) Post training
Implementation Smoking Cessation Counseling Scale (RN) During implementation
SBIRT Use and time estimates for each component (SN) Post implementation, 5 randomly selected days
Implementation fidelity assessment survey (SC) Post implementation
Monthly worksheet (SC) Continuously
Consequences SBIRT component documentation in medical record (electronic data abstraction 
and SC manual data abstraction)
Baseline, 6, and 12 months
Time estimates for each component delivery (SN) Post implementation, 5 randomly selected days
Training details (e.g., number trained, meeting time, administrative time, etc.) with 
implementation fidelity assessment survey (SC)
Post implementation
Barriers, facilitators, lessons learned through interviews (SC) Post implementation
End of data collection
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study to assess knowledge about screening tools, moti-
vational strategies, and referral tools. In addition, com-
petency will be assessed using the Brief Intervention 
Adherence and Competence Scale [56]. These data will 
be used to evaluate training and verify SBIRT knowledge 
and competency.
Actual implementation will be assessed using several 
strategies. Each month, site coordinators will complete 
a qualitative and quantitative monthly worksheet devel-
oped by the investigators that includes information about 
the time spent on implementation, changes in care pro-
cesses, barriers and facilitators to implementation, and 
lessons learned. On five randomly selected days, site 
coordinators will collect quantitative data regarding 
SBIRT use. After each patient admission on the randomly 
selected days, the direct care nurse or site coordinator 
will complete a survey regarding fidelity to the different 
components of SBIRT and the time required to complete 
SBIRT for that patient. Site coordinators will also com-
plete a survey regarding implementation fidelity. This 
quantitative and qualitative survey includes questions 
about the number of nurses trained in SBIRT and actions 
taken to support SBIRT implementation. Finally, all direct 
care nurses on the study units (including nurses who did 
not receive training in SBIRT) will be invited to complete 
the Smoking Cessation Counseling Scale [57–59]. This 
survey assesses the extent to which clinicians comply 
with evidence-based smoking cessation guidelines. Data 
from the monthly worksheets, SBIRT use assessment, 
implementation fidelity assessment, and smoking cessa-
tion counseling scale will be reviewed by the investigators 
at the completion of data collection. This information will 
inform feedback to site coordinators, identify barriers 
and facilitators to implementation, and inform potential 
modifications to implementation strategies.
The consequences of SBIRT implementation include 
the delivery of SBIRT components and the costs of 
implementation. Delivery of SBIRT components will be 
measured by the documentation of screening, brief inter-
vention, and referral to treatment for alcohol, drugs, and 
tobacco, individually and combined. These data will be 
based on the Joint Commission Quality Measures for 
alcohol, drug, and tobacco use [60]. The components 
of SBIRT will be documented in the medical record 
by healthcare providers who complete the screening, 
brief intervention, and referral to treatment. All hos-
pitals use the same electronic medical record system. 
Sixty-one medical records at each site will be randomly 
selected through automated processes. Inclusion criteria 
are adult (≥ 18) patients admitted and discharged from 
units selected for participation in this study within data 
abstraction periods (baseline, 6 months and 12 months). 
De-identified data will be abstracted using an electronic 
data abstraction report. Automated data abstraction will 
be validated via comparison of electronic and manual 
data abstraction in a sub-sample of records at each hos-
pital. If required, the site coordinators will conduct the 
medical record review manually. We will collect data 
regarding the number of patients screened for alcohol, 
tobacco, and drugs using a validated tool, and the per-
centage of patients who screened positive for each sub-
stance and then received a brief intervention and/or 
referral to treatment. The costs of implementation will 
be assessed using the monthly worksheets completed by 
the site coordinators and the SBIRT use reports. Data 
regarding care delivery and costs of implementation will 
be assessed. At the completion of the study, site coor-
dinators will complete a semi-structured interview to 
describe their experiences as well as barriers and facilita-
tors of implementation.
Statistical analysis
A sample size calculation was conducted to determine 
the number of medical records needed in each of the 
14 study hospitals, to achieve an 80% power at an alpha 
level of 0.05 to address the quantitative aims of the study 
while taking the clustered randomization into considera-
tion [61, 62]. Sample size calculations were based on an 
intracluster correlation of 0.03. In case intracluster cor-
relation is lower than 0.03, our statistical tests provide 
an even larger statistical power. For the between-group 
comparisons regarding the binary outcomes of Aim 1, 
detecting an absolute difference in a proportion between 
the two groups of 16% with an at least 80% power, using 
a Z-statistic that accounts for the intracluster correlation, 
requires 61 medical records per hospital. Based on this 
sample size for each observation time-point, we are also 
sufficiently powered to test for within group changes in 
the control group (post-intervention vs pre-intervention) 
since within-group comparisons are expected to have a 
larger power compared to between-group comparisons. 
Sample size calculations were conducted using the PASS 
13 software.
The analysis has been a priori defined to address the 
research aims. Descriptive statistics will be computed 
for all variables to ensure data quality, identify patterns 
of missing and out-of-range values, and evaluate the 
assumptions of statistical tests. In general, missing data 
will be evaluated considering both descriptive statistics 
and possible reasons for non-response. The assumption 
of missing at random (MAR) [63] is evaluated based on 
extensive data considerations and discussions with the 
data collecting personnel on the reasons for nonresponse 
for the non-medical record data. If the MAR assumption 
is plausible, multiple imputation methodology will be 
applied [64]. If there are missing data in more than one 
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variable, multiple imputation through chained equations 
will be performed [65]. Inclusion of auxiliary variables 
that are associated with the probability of missingness 
in the imputation model will be considered in order to 
make the MAR assumption more plausible. In this case, 
standard errors will be estimated through nonparametric 
bootstrap methods in order to avoid the consequences 
of uncongeniality between the imputation and analysis 
models on Rubin’s standard error estimator [66, 67]. If 
there are no variables that make the MAR assumptions 
plausible, a sensitivity analysis will be performed under 
various missing not at random scenarios to evaluate the 
robustness of inference against the violation of the MAR 
assumption. Remediation of normal distribution assump-
tion violations will be accomplished using methods such 
as the Box-Cox family transformations, or other methods 
as appropriate. Assessment of internal consistency reli-
ability of scales will be carried out using the Cronbach’s 
alpha coefficient. Analysis for each study aim will be per-
formed using the statistical packages SAS or STATA. Any 
imbalances due to chance will be addressed by including 
the corresponding variables as covariates in the multi-
variable regression models for each outcome. Intention-
to-treat analysis will be performed in accordance to the 
pragmatic trial model, in the sense that all participating 
units will be included in the analysis regardless of their 
level of adherence to SBIRT.
Aim 1
Evaluation of the effect of implementation strategies 
will be focused  on the use of SBIRT. To estimate the 
effect of implementation (training, toolkit) of SBIRT on 
clinical processes, we will use multilevel mixed-effects 
logistic regression models to account for both the hos-
pital unit clustering effects and the potential observation 
dependence within each phase of the study (i.e., baseline, 
6 months, 12 months), while adjusting for variables found 
to be imbalanced between the study groups. Potential 
confounders such as organizational and nurse attributes 
will also be considered for inclusion in the model to avoid 
any residual confounding effects. Based on these mod-
els, both between and within-group effects will be esti-
mated and model-based estimates of the effect size (i.e., 
odds ratio) will be calculated along with the associated 
95% confidence intervals. We will additionally evalu-
ate the intervention effect sustainability in the interven-
tion group by comparing, using the appropriate estimate 
from the fitted model, the proportion of SBIRT use at 
6 months versus the corresponding use at 12 months.
Aim 2
Evaluation of the cost of implementation and deliv-
ery of SBIRT will be focused on the system perspective. 
Tailored implementation of SBIRT for local healthcare 
settings requires appropriate budgeting and resources. 
Data on both human resources and tangible resource 
use will be measured during the current study. These 
data will inform future implementation and budgeting. 
We will estimate costs of implementation based upon 
phase of implementation, including the start-up, deploy-
ment, and maintenance costs of the adoption of SBIRT. 
Specific cost categories will collected via the monthly 
worksheet including personnel (training & education; 
deployment), site coordinator time spent on implementa-
tion, and SBIRT related expenses (e.g., written materials). 
Costs of SBIRT delivery will be estimated using a random 
sample of registered nurse’s report of estimated minutes 
interacting with the patient during the SBIRT process. 
The cost outcomes will be analyzed using mixed-effects 
linear regression models to account for the hospital unit 
clustering.
Qualitative analysis
Post study structured phone interviews will be con-
ducted with site coordinators. The responses to questions 
include pre-defined categories and a narrative, which 
will be documented by the investigator and verified with 
the participant. Quasi-statistics will be used to report 
the categories of responses. Narrative comments will be 
reviewed, coded and categorized by two independent 
study team members.
Discussion
There are a number of strengths and limitations of this 
study related to the design, methods, and primary end-
points/outcomes. In terms of strengths, the use of a clus-
ter randomized phased approach allows comparison of 
an intervention and control group, as well as within hos-
pital differences before and after implementation of the 
intervention. It also allows both groups to participate 
in the intervention and implementation (providing data 
from 14 hospital unites to inform implementation guides 
for future use). Using a mixed method approach will pro-
vide data from multiple sources including observations, 
survey, interviews and secondary data from EMRs to 
inform the evaluation. The collection of organizational 
and implementation assessments will inform lessons 
from successful and ailed strategies with a specific focus 
on nurse barriers identified by Désy et al. [68]. It is also 
important to note that this study is being conducted at a 
time when the opioid epidemic is a major public health 
priority and health systems are seeking better processes 
to identify and treat people with risky substance use.
Despite these strengths there are a number of limita-
tions of the study including use of process endpoints 
instead of patient outcomes, the implementation 
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process time/skill/resource demand, and use of the 
EMR data. The absence of patient clinical outcomes 
precludes the ability to evaluate if the intervention 
resulted in lower substance use, treatment success or 
patient experience. Given the current lack of strong 
evidence for SBIRT on such outcomes for all substances 
that are being targeted (e.g., drugs), a study linking 
SBIRT in medical units is needed. This study provides 
the first step toward studies of clinical outcomes by 
evaluating if this evidence-based practice is usable, 
implementable and if patients actually receive the care 
they should- and how to implement the intervention. 
Another limitation is the time demand in learning how 
to use and implement SBIRT given multiple priorities 
for clinical nurses. While projected time estimates were 
shared with nurse executives, and release time from 
clinical duties planned and budgeted in the grant were 
estimated, there is a learning curve and nurse staffing 
can vary day to day.
Use of medical record documentation to assess SBIRT 
consequences may also present a threat to study valid-
ity. Compliance with processes of care captured in EMR 
documentation is typically used to evaluate the quality 
of services rendered. There is a possibility that at base-
line there may be nothing documented beyond the initial 
screening for substance use. Even after the education, 
implementation may require additional time and it may 
take longer than 6 months for practice to change. A nurse 
self-report of SBIRT use on the last admitted patient on 
randomly selected days will be included, providing data 
that can be used to correlate with the EMR data.
Conclusion
This study addresses a major public health concern—
identifying, intervening, and referring people to treat-
ment with risky substance use. A phased cluster 
randomized mixed method design will be used to eval-
uate implementation of SBIRT in acute care medical 
surgical unit by nurses and develop an SBIRT toolkit 
to enhance broad dissemination. Results of this study 
will affect clinical practice, health system processes 
and implementation and has the potential to standard-
ize the SBIRT process enhancing action toward helping 
people reduce substance use risks and get treatment if 
appropriate- a significant innovation to current prac-
tice on medical surgical units.
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